BSETitan Biotech LtdMinimalNeutral
Announced Sat, 4 Apr · 17:12 IST

Compliance Certificate under Regn 74(5) of SEBI (DP) Regulations, 2018

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.2%1-day move
₹504.00
prior close
₹514.80
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.6+2.6+2.8+2.8-0.2-5.1-9.9-14.4-18.7-10.3-9.7-6.4-13.3-18.9
Up moveDown movePending
AI summary

Titan Biotech Ltd has submitted a routine compliance certificate confirming that securities received for dematerialization during the quarter ending March 2026 were properly processed by their Registrar and Transfer Agent, Beetal Financial & Computer Services (P) Ltd. The certificate verifies that dematerialization requests were confirmed to depositories (NSDL/CDSL), security certificates were mutilated and cancelled, and depository names were substituted as registered owners within the required 15-day timeframe. This is a standard regulatory filing required under SEBI regulations for all listed companies. The company scrip is listed on BSE with code 524717.

Likely market impact

This is a routine compliance filing with no direct impact on shareholders or stock price. It simply confirms proper processing of dematerialization requests as mandated by SEBI regulations.